Kaken Pharmaceutical Co., Ltd.

TSE:4521.T

3901 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 8,0256,81713,88518,65726,59224,92227,68631,09235,29218,61115,49614,17814,56613,54510,9299,3548,6037,7837,3276,081
Depreciation & Amortization 2,7532,5682,4862,3182,3122,1532,1241,9372,2422,4002,5382,6072,4242,4882,4232,4072,2801,9771,9401,995
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital -6,359592-2,041-1,5456,3874,558-3,018-1,719-3,385-4,1711,932611-1,30525822-1,3682,9072,0181,396171
Accounts Receivables -4,5599723921,2518,5392,975-5,0841,637-1,664-2,8415,81185800000000
Inventory -1,603-583241-2,9231,4462,930-155-1,987-1,025-260-1,690-605-625-1,3071,953-1,008-811530592809
Accounts Payables 880280-2,630-112-3,576-1,1932,290-1,094-3800000000000
Other Working Capital -1,077-77-44239-22-154-2,863268-2,360-3,9113,6221,216-6801,332-1,131-3603,7181,488804-638
Other Non Cash Items 8,946-724-994-5,050-7,823-10,504-5,089-15,983-7,082-2,103-6,303-5,667-5,400-2,916-3,125-1,921-3,776155-4,317230
Operating Cash Flow 2,5779,25313,33614,38027,46821,12921,70315,32727,06714,73713,66311,72910,28513,14211,0498,47210,01411,9336,3468,477
Investing Activities:
Investments In Property Plant And Equipment -2,167-2,206-3,257-2,286-2,202-2,128-1,888-2,354-3,217-2,028-2,126-3,914-2,529-5,086-2,625-2,659-2,383-1,836-1,586-1,455
Acquisitions Net 1-207-4,97556100199-188000-6900-117-8232806430
Purchases Of Investments 0-200433-200-1-1,253-1,502-753-3-3-1,813-3-1,001-332-457-2-356-3,669-233
Sales Maturities Of Investments 516551445014830001480082550134802,6000
Other Investing Activites -4,204-19-94-43-331-3,615-30458-1352,504-6-1,144-31-215-125126-17-30-11118
Investing Cash Flow -5,854-2,627-7,888-1,644-2,528-5,744-3,245-3,503-4,105473-2,135-6,792-2,563-6,302-2,374-2,571-1,726-2,222-2,023-1,570
Financing Activities:
Debt Repayment 0000-25000-3200000-1200-3,000000-607
Common Stock Issued 00002500000000000000-430
Common Stock Repurchased 0-1,340-2,414-2,940-4,252-3,523-3,445-3,512-201-3,636-2,860-2,20200000-5,796-2,073-773
Dividends Paid -5,657-5,649-5,714-5,811-5,896-6,001-6,085-6,288-5,463-4,263-3,936-3,664-3,413-3,088-2,745-2,320-1,967-1,682-1,278-1,063
Other Financing Activities -1-1-1-1-250-3,445-3,512-521-3,637-7,056-2,203-3,491-4,101-982-410-5,8480-8,561-2
Financing Cash Flow -5,658-6,990-8,129-8,752-10,173-9,524-9,530-9,800-5,984-7,900-10,992-5,867-6,904-7,309-3,727-5,730-7,815-7,478-11,912-2,875
Other Information:
Effect Of Forex Changes On Cash 0-11-100-1-1-101-1-200-1-10-1-1
Net Change In Cash -8,936-365-2,6803,98314,7675,8618,9272,02316,9777,310537-931816-4694,9481704722,233-7,5904,031
Cash At End Of Period 65,32474,26074,62577,30573,32258,55552,69443,76741,74424,76717,45716,92017,85117,03517,50412,55612,38611,9149,68117,271